Breast Cancer Prevention Study: Are Healthy Women Put at Risk by Federally Funded Research? : Hearing Before the Human Resources and Intergovernmental Relations Subcommittee of the Committee on Government Operations, House of Representatives, One Hundred Second Congress, Second Session, October 22, 1992
United States, United States. Congress. House. Committee on Government Operations. Human Resources and Intergovernmental Relations Subcommittee
U.S. Government Printing Office, 1994 - 272 páginas
Comentarios de la gente - Escribir un comentario
No encontramos ningún comentario en los lugares habituales.
Otras ediciones - Ver todas
addition adjuvant Administration Advisory American animals approved associated believe benefits blood bone breast cancer breast cancer prevention cause centers Chairman changes clinical trials Committee concern consent form considered continue developing breast cancer Director disease document doses drug early endometrial estrogen Evaluation evidence findings five given going Health healthy women heart high risk human important incidence increased indicated individual informed consent initial involving issue known liver cancer major months myocardial infarction National Cancer noted NSABP occurred Oncology participants patients PAYNE percent physician placebo population possible postmenopausal potential premenopausal women prevention trial primary problems Project protocol questions rats receiving recruitment reduce reported risk safety says serious side effects statement subjects suggest taking tamoxifen tests therapy tion toxicity treated treatment tumors understand University uterine woman
Página 37 - American Public Health Association 1015 15th Street NW Washington, DC 20005 (202) 789-5600...
Página 26 - Gail MH, Brinton LA, Byar DP, et aL Projecting individualized probabilities of developing breast cancer for white females who are being examined annually.
Página 5 - Committee, all witnesses before the committee will be sworn in. From time to time during the hearing, we will be inserting into the record, without objection, documents relevant to this matter. Before we begin, let me say to all of our witnesses that the full text of your written statements will be inserted in the hearing record.
Página 55 - My colleagues and I will be pleased to respond to your questions. [The prepared statement of Dr.
Página 11 - Shortly thereafter, in 1974, the National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research was created.
Página 79 - A clinical trial to determine the worth of tamoxifen for preventing breast cancer.
Página 5 - Operations, all witnesses before the committee will be sworn in. From time to time during the hearing we will be inserting into the record, without objection, documents relevant to this matter. Before we begin, let me say to all of our witnesses that the full text of your written statements will be inserted into the hearing record.
Página 1 - Washington, DC. The subcommittee met, pursuant to notice, at 10:07 am, in room 2154, Rayburn House Office Building, Hon.